Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DC52UD
|
|||
| Drug Name |
CTP-692
|
|||
| Synonyms |
Deutarserine; D-serine-2-d; Deutarserine [USAN]; UNII-OD54L0MH86; OD54L0MH86; SCHEMBL10901499; WHO 11514; (2R)-2-amino-2-deuterio-3-hydroxypropanoic acid; C-21692; 103292-62-2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Phase 2 | [1] | |
| Company |
Concert Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C3H7NO3
|
|||
| Canonical SMILES |
C(C(C(=O)O)N)O
|
|||
| InChI |
1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1/i2D
|
|||
| InChIKey |
MTCFGRXMJLQNBG-LIIDHCAMSA-N
|
|||
| CAS Number |
CAS 103292-62-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04158687) A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.